Back
Speaker illustration

undefined undefined undefined

Presentations Articles

Temporal Trends in HF Outcomes

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Late Breaking Clinical Science: global insights and outcomes in heart failure

Access
Like
Thumbnail

Evaluating the clinical consequences of atrial fibrillation in asian women with breast cancer

Event: ESC Cardio-Oncology 2025

Topic: Stratification, Prevention and Monitoring

Session: Poster session (2)

Access
Like
Thumbnail

Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure on replacement therapy

Event: Heart Failure 2025

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Advancing heart failure diagnosis and management: insights from hemodynamics, inflammation, and emerging therapies

Access
Like
Thumbnail

Temporal trends and clinical characteristics of variant versus wild-type transthyretin amyloid cardiomyopathy in Asian population: the Korean nationwide cohort study

Event: Heart Failure 2024

Topic: Clinical

Session: Myocardial disease - clinical 3

Access
Like
Thumbnail

A budget impact analysis of empagliflozin for heart failure patients with full spectrum of ejection fraction in South Korea

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 6

Access
Like
Thumbnail

Cost-utility analysis and eligibility of dapagliflozin for patients with heart failure across the whole spectrum of ejection fraction

Event: Heart Failure 2023

Topic: Pharmacotherapy

Session: Chronic heart failure - pharmacotherapy 5

Access
Like
Thumbnail

CD4+CD57+ T cells are increased and associated with clinical outcome in patients with acute heart failure

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cytokines and inflammation

Session: Cytokines and inflammation

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources